Search | TVST | ARVO Journals

Showing 1 – 20 of 22

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Suture Erosion in Scleral-Supported PCIOL with Scleral Lens Wear

Hannah Ngo; Odette M Houghton; Dharmendra R. Patel; Eric R. Kawulok; Joanne F Shen

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2682.

ARVO Annual Meeting Abstract June 2024

Diagnosis Algorithm for Ocular Mucous Membrane Pemphigoid

Hunter Stearns; Emma Terwilliger; Yul Yang; Aaron Mangold; Joanne F Shen

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3631.

ARVO Annual Meeting Abstract June 2024

Treatment of Ocular Mucous Membrane Pemphigoid

Emma Terwilliger; Hunter Stearns; Yul Yang; Aaron Mangold; Joanne F Shen

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3627.

ARVO Annual Meeting Abstract June 2024

Treatment of Filamentary Keratitis in Chronic GVHD Patients

Connor Mayes; Joanne F Shen

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4134.

Public Health March 2024

Insights Into Eye Care Accessibility: Geospatial Distribution of Eye Care Providers and Socioeconomic Factors by ZIP Code

PDF

Meagan T. Tran; Valeria V. Gonzalez; Carolyn Mead-Harvey; Joanne F. Shen
TAGS: eye care, socioeconomic factors, optometrists, ophthalmologists
Trans. Vis. Sci. Tech.. 2024; 13(3):21. https://doi.org/10.1167/tvst.13.3.21

ARVO Annual Meeting Abstract June 2023

Association of Socioeconomic Factors and Geospatial Distribution of Eye Care Providers

Meagan T Tran; Carolyn Mead-Harvey; Joanne F Shen

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3042.

ARVO Annual Meeting Abstract June 2023

Presumed Fibrinogen Clot Precluding Autologous Serum Tears Production

Maya Harrington; Joanne F Shen

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3956.

ARVO Annual Meeting Abstract June 2023

Intraocular lens (IOL) implantation in the absence of zonular support

Hannah Phuong Uyen Ngo; Odette Houghton; Dharmendra (Dave) Patel; Eric Kawulok; Joanne F Shen

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3319.

ARVO Annual Meeting Abstract June 2020

TGF-β1 and microbiome analysis following Intense Pulsed Light with Meibomian Gland Expression for dry eye symptoms from meibomian gland disease and ocular rosacea

Samantha Sagaser; Richard Butterfield; Heidi Kosiorek; Yael Kusne; Juan Maldonado; Michael Fautsch; Dave Patel; Joanne F Shen

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):104.

ARVO Annual Meeting Abstract June 2020

Autologous Serum Tears for Refractory Ocular Surface Disorders

Crystal Huang; Joanne F Shen

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):122.

ARVO Annual Meeting Abstract June 2020

Efficacy of a Treatment Protocol for Chronic Ocular GVHD Patients

Jose Omar Garcia; Carolyn Mead-Harvey; Richard Butterfield; Joanne F Shen

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):123.

Articles April 2020

Climatic and Environmental Correlates of Dry Eye Disease Severity: A Report From the Dry Eye Assessment and Management (DREAM) Study

PDF

Erich J. Berg; Gui-shuang Ying; Maureen G. Maguire; Perry E. Sheffield; Loretta B. Szczotka-Flynn; Penny A. Asbell; Joanne F. Shen; the DREAM Study Research Group
TAGS: dreams, dry eye syndromes, signs and symptoms, climate
Trans. Vis. Sci. Tech.. 2020; 9(5):25. https://doi.org/10.1167/tvst.9.5.25

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

Seven Common Allergen Groups of Eyelid Dermatitis: Education and Avoidance Strategies

Crystal Huang; James Yiannias; Jill Killian; Joanne F Shen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6711.

ARVO Annual Meeting Abstract July 2019

Intense pulsed light therapy with meibomian gland expression vs meibomian gland expression for treatment of dry eye in ocular rosacea

Samantha Sagaser; Richard Butterfield; Heidi Kosiorek; Yael Kusne; William M Bourne; Michael Fautsch; Dave Patel; Joanne F Shen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6733.

ARVO Annual Meeting Abstract July 2018

Environmental factors and symptoms and signs of dry eye disease at baseline in the Dry Eye Assessment and Management (DREAM © ) Study

Joanne F Shen; Erich Berg; Gui-Shuang Ying; Perry Sheffield; Loretta Szczotka-Flynn

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1963.

ARVO Annual Meeting Abstract June 2017

Ocular Severity does not predict mortality or systemic severity in chronic GVHD patients

Yael Kusne; Nandita Khera; Joanne F Shen

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2243.

ARVO Annual Meeting Abstract June 2017

Botulinum toxin A use in dry eye patients with superior limbic keratoconjunctivitis (SLK)

Joanne F Shen; Yael Kusne

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2698.

ARVO Annual Meeting Abstract September 2016

Correlation of conjunctival subepithelial fibrosis and meibomian gland atrophy in chronic ocular GVHD

Yael Kusne; Joanne F Shen

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5696.

ARVO Annual Meeting Abstract June 2015

Tear osmolarity measurements in ocular graft-versus-host disease patients undergoing intense pulsed light (IPL) and meibomian gland expression (MGX)

Srav Vegunta; Qing Wu; Joanne F Shen

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):358.

ARVO Annual Meeting Abstract June 2015

Intense pulsed light (IPL) and meibomian gland expression (MGX) treatment of ocular rosacea and dry eye disease (DED) in chronic graft-versus-host disease (cGVHD): 12 month pilot study

Joanne F Shen; Srav Vegunta; Qing Wu; Dharmendra (Dave) Patel; Nandita Khera

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4441.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Suture Erosion in Scleral-Supported PCIOL with Scleral Lens Wear

Diagnosis Algorithm for Ocular Mucous Membrane Pemphigoid

Treatment of Ocular Mucous Membrane Pemphigoid

Treatment of Filamentary Keratitis in Chronic GVHD Patients

Insights Into Eye Care Accessibility: Geospatial Distribution of Eye Care Providers and Socioeconomic Factors by ZIP Code

Association of Socioeconomic Factors and Geospatial Distribution of Eye Care Providers

Presumed Fibrinogen Clot Precluding Autologous Serum Tears Production

Intraocular lens (IOL) implantation in the absence of zonular support

TGF-β1 and microbiome analysis following Intense Pulsed Light with Meibomian Gland Expression for dry eye symptoms from meibomian gland disease and ocular rosacea

Autologous Serum Tears for Refractory Ocular Surface Disorders

Efficacy of a Treatment Protocol for Chronic Ocular GVHD Patients

Climatic and Environmental Correlates of Dry Eye Disease Severity: A Report From the Dry Eye Assessment and Management (DREAM) Study

Seven Common Allergen Groups of Eyelid Dermatitis: Education and Avoidance Strategies

Intense pulsed light therapy with meibomian gland expression vs meibomian gland expression for treatment of dry eye in ocular rosacea

Environmental factors and symptoms and signs of dry eye disease at baseline in the Dry Eye Assessment and Management (DREAM © ) Study

Ocular Severity does not predict mortality or systemic severity in chronic GVHD patients

Botulinum toxin A use in dry eye patients with superior limbic keratoconjunctivitis (SLK)

Correlation of conjunctival subepithelial fibrosis and meibomian gland atrophy in chronic ocular GVHD

Tear osmolarity measurements in ocular graft-versus-host disease patients undergoing intense pulsed light (IPL) and meibomian gland expression (MGX)

Intense pulsed light (IPL) and meibomian gland expression (MGX) treatment of ocular rosacea and dry eye disease (DED) in chronic graft-versus-host disease (cGVHD): 12 month pilot study

To View More...

You must be signed into an individual account to use this feature.